U.S. Vascular Closure Devices Market

U.S. Vascular Closure Devices Market

Analysis by Type (Passive Approximators: Collagen Plugs, Sealant or Gel-based Devices, Compression Assist Devices; Active Approximators: Suture-based Devices, Clip-based Devices; External Hemostatic Devices), Access (Femoral, Radial) and Procedure (Interventional Cardiology, Interventional Radiology/Vascular Surgery)

Report ID: HP03 | Format: PDF, Excel | Publish Date: November 2026 | Pages: 120

1. Executive Summary
•    1.1 Key Findings
•    1.2 Market Snapshot: Value, Units and Blended ASP, 2024, 2025 and 2032
•    1.3 Analyst Viewpoint
2. Research Methodology
•    2.1 Research Scope and Market Definition
•    2.2 Data Sources: Primary and Secondary Research
•    2.3 Market Sizing Approach: Procedure-Based and Vendor Revenue Models
•    2.4 Unit Volume and ASP Estimation
•    2.5 Forecasting Assumptions and Data Triangulation
•    2.6 Abbreviations
3. U.S. Vascular Closure Devices Market Outlook
•    3.1 Market Value, 2020–2032 (US$ Million)
•    3.2 Year-on-Year Growth, 2021–2032
•    3.3 Unit Volume, 2020–2032 (Million Units)
•    3.4 Blended Average Selling Price, 2020–2032
4. Market Dynamics
•    4.1 Drivers
•    4.1.1 Growth of Structural Heart and Electrophysiology Procedures
•    4.1.2 Same-Day Discharge and Laboratory Throughput
•    4.1.3 Growth in Peripheral and Venous Interventions
•    4.2 Restraints
•    4.2.1 Femoral-to-Radial Access Shift
•    4.2.2 GPO Pricing Pressure
•    4.3 Opportunities
•    4.3.1 Large-Bore Arterial Closure
•    4.3.2 Venous Closure for Electrophysiology
•    4.3.3 Ambulatory Surgery Centers and Office-Based Labs
•    4.4 Challenges
•    4.4.1 Access Site Complications and Clinical Evidence Requirements
•    4.4.2 Procedure Technology Shifts (e.g., Pulsed Field Ablation)
5. Hospital Economics and Adoption Analysis
•    5.1 Closure Device vs Manual Compression Economics
•    5.2 Reimbursement Context
•    5.3 Purchasing and Contracting Trends
6. Price-Mix Analysis
•    6.1 Value Share vs Unit Share by Device Type
•    6.2 Average Selling Price by Device Type, 2020–2032
•    6.3 Sources of Incremental Growth, 2024–2032
7. Market Analysis by Type (Value and Units, 2020–2032)
•    7.1 Passive Approximators
•    7.1.1 Collagen Plugs
•    7.1.2 Sealant or Gel-based Devices
•    7.1.3 Compression Assist Devices
•    7.2 Active Approximators
•    7.2.1 Suture-based Devices
•    7.2.2 Clip-based Devices
•    7.3 External Hemostatic Devices
8. Market Analysis by Access (Value, 2020–2032)
•    8.1 Femoral Access
•    8.2 Radial Access
9. Market Analysis by Procedure (Value, 2020–2032)
•    9.1 Interventional Cardiology
•    9.2 Interventional Radiology/Vascular Surgery
10. Regulatory Landscape
•    10.1 FDA Premarket Approval Pathway for Closure Devices
•    10.2 Recent Approvals and Label Expansions
•    10.3 Post-Market Surveillance and Recalls
11. Competitive Landscape
•    11.1 Market Structure and Concentration
•    11.2 Recent Acquisitions, Divestitures and Ownership Changes
•    11.3 Epignosis Insights Competitive Assessment Framework (EICAF)
•    11.4 EICAF Scoring Method and Company Rankings
12. Company Profiles
•    12.1 Abbott
•    12.2 Terumo
•    12.3 Haemonetics (incl. Vivasure Medical)
•    12.4 Cordis
•    12.5 Teleflex
•    12.6 Merit Medical Systems
•    12.7 Other Emerging Players
•    Each profile: Company Overview, Closure Portfolio, Clinical Evidence, Financial Snapshot, Recent Developments
13. Strategic Recommendations
•    13.1 For Device Manufacturers
•    13.2 For Hospitals and Purchasing Organizations
•    13.3 For Investors
14. Appendix
•    14.1 List of Tables
•    14.2 List of Figures
•    14.3 Disclaimer

Frequently Asked Questions

What is the U.S. vascular closure devices market size in 2025?
The U.S. vascular closure devices market is valued at approximately US$655.0 million in 2025, according to Epignosis Insights estimates.
What is the expected market size by 2032?
The market is projected to reach approximately US$1,013.5 million by 2032, representing a 6.2% CAGR from 2024 to 2032.
How many vascular closure devices are sold in the U.S.?
Epignosis Insights estimates that about 3.74 million units will be sold in 2025, rising to around 5.98 million units by 2032.
Which device type holds the largest share?
Suture-based devices are the largest category by value, at about 40.7% of the 2025 market, while compression assist devices lead by units.
Which access type is growing fastest?
Radial access closure is growing faster, at a 7.1% CAGR between 2024 and 2032, compared with 5.9% for femoral access.

Small Analyst Support Card

Need Help Choosing the Right Report

Talk to Our Analyst